Literature DB >> 16982824

Lack of in vitro and in vivo recognition of Francisella tularensis subspecies lipopolysaccharide by Toll-like receptors.

Adeline M Hajjar1, Megan D Harvey, Scott A Shaffer, David R Goodlett, Anders Sjöstedt, Helen Edebro, Mats Forsman, Mona Byström, Mark Pelletier, Christopher B Wilson, Samuel I Miller, Shawn J Skerrett, Robert K Ernst.   

Abstract

Francisella tularensis is an intracellular gram-negative bacterium that is highly infectious and potentially lethal. Several subspecies exist of varying pathogenicity. Infection by only a few organisms is sufficient to cause disease depending on the model system. Lipopolysaccharide (LPS) of gram-negative bacteria is generally recognized by Toll-like receptor 4 (TLR4)/MD-2 and induces a strong proinflammatory response. Examination of human clinical F. tularensis isolates revealed that human virulent type A and type B strains produced lipid A of similar structure to the nonhuman model pathogen of mice, Francisella novicida. F. novicida LPS or lipid A is neither stimulatory nor an antagonist for human and murine cells through TLR4 or TLR2. It does not appear to interact with TLR4 or MD-2, as it is not an antagonist to other stimulatory LPS. Consistent with these observations, aerosolization of F. novicida LPS or whole bacteria induced no inflammatory response in mice. These results suggest that poor innate recognition of F. tularensis allows the bacterium to evade early recognition by the host innate immune system to promote its pathogenesis for mammals.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16982824      PMCID: PMC1698081          DOI: 10.1128/IAI.00934-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Detergent-accelerated hydrolysis of bacterial endotoxins and determination of the anomeric configuration of the glycosyl phosphate present in the "isolated lipid A" fragment of the Bordetella pertussis endotoxin.

Authors:  M Caroff; A Tacken; L Szabó
Journal:  Carbohydr Res       Date:  1988-04-15       Impact factor: 2.104

2.  The ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and neutrophil adhesion.

Authors:  R P Darveau; M D Cunningham; C L Seachord; R C Page; A Aruffo
Journal:  Prog Clin Biol Res       Date:  1995

3.  Novel modification of lipid A of Francisella tularensis.

Authors:  Nancy J Phillips; Birgit Schilling; Molly K McLendon; Michael A Apicella; Bradford W Gibson
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

4.  Worldwide genetic relationships among Francisella tularensis isolates determined by multiple-locus variable-number tandem repeat analysis.

Authors:  Anders Johansson; Jason Farlow; Pär Larsson; Meghan Dukerich; Elias Chambers; Mona Byström; James Fox; May Chu; Mats Forsman; Anders Sjöstedt; Paul Keim
Journal:  J Bacteriol       Date:  2004-09       Impact factor: 3.490

Review 5.  Endotoxins: relationships between structure, function, and activity.

Authors:  Klaus Brandenburg; Andre Wiese
Journal:  Curr Top Med Chem       Date:  2004       Impact factor: 3.295

6.  Improved preparation of lipoteichoic acids.

Authors:  W Fischer; H U Koch; R Haas
Journal:  Eur J Biochem       Date:  1983-07-01

7.  Analysis of 16S ribosomal DNA sequences of Francisella strains and utilization for determination of the phylogeny of the genus and for identification of strains by PCR.

Authors:  M Forsman; G Sandström; A Sjöstedt
Journal:  Int J Syst Bacteriol       Date:  1994-01

8.  Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes.

Authors:  D T Golenbock; R Y Hampton; N Qureshi; K Takayama; C R Raetz
Journal:  J Biol Chem       Date:  1991-10-15       Impact factor: 5.157

9.  Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization.

Authors:  Shin-ichiroh Saitoh; Sachiko Akashi; Takenao Yamada; Natsuko Tanimura; Makiko Kobayashi; Kazunori Konno; Fumi Matsumoto; Koichi Fukase; Shoichi Kusumoto; Yoshinori Nagai; Yutaka Kusumoto; Atsushi Kosugi; Kensuke Miyake
Journal:  Int Immunol       Date:  2004-06-07       Impact factor: 4.823

10.  A novel Escherichia coli lipid A mutant that produces an antiinflammatory lipopolysaccharide.

Authors:  J E Somerville; L Cassiano; B Bainbridge; M D Cunningham; R P Darveau
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

View more
  98 in total

1.  Proteomic analysis of bronchoalveolar lavage fluid proteins from mice infected with Francisella tularensis ssp. novicida.

Authors:  Susan M Varnum; Bobbie-Jo M Webb-Robertson; Joel G Pounds; Ronald J Moore; Richard D Smith; Charles W Frevert; Shawn J Skerrett; David Wunschel
Journal:  J Proteome Res       Date:  2012-06-22       Impact factor: 4.466

2.  Francisella tularensis Schu S4 O-antigen and capsule biosynthesis gene mutants induce early cell death in human macrophages.

Authors:  Stephen R Lindemann; Kaitian Peng; Matthew E Long; Jason R Hunt; Michael A Apicella; Denise M Monack; Lee-Ann H Allen; Bradley D Jones
Journal:  Infect Immun       Date:  2010-11-15       Impact factor: 3.441

3.  Detoxified endotoxin vaccine (J5dLPS/OMP) protects mice against lethal respiratory challenge with Francisella tularensis SchuS4.

Authors:  Stephen H Gregory; Wilbur H Chen; Stephanie Mott; John E Palardy; Nicholas A Parejo; Sara Heninger; Christine A Anderson; Andrew W Artenstein; Steven M Opal; Alan S Cross
Journal:  Vaccine       Date:  2010-02-17       Impact factor: 3.641

Review 4.  Sensing gram-negative bacterial lipopolysaccharides: a human disease determinant?

Authors:  Robert S Munford
Journal:  Infect Immun       Date:  2007-12-17       Impact factor: 3.441

5.  Structural heterogeneity and environmentally regulated remodeling of Francisella tularensis subspecies novicida lipid A characterized by tandem mass spectrometry.

Authors:  Scott A Shaffer; Megan D Harvey; David R Goodlett; Robert K Ernst
Journal:  J Am Soc Mass Spectrom       Date:  2007-03-28       Impact factor: 3.109

6.  The Francisella O-antigen mediates survival in the macrophage cytosol via autophagy avoidance.

Authors:  Elizabeth Di Russo Case; Audrey Chong; Tara D Wehrly; Bryan Hansen; Robert Child; Seungmin Hwang; Herbert W Virgin; Jean Celli
Journal:  Cell Microbiol       Date:  2013-12-16       Impact factor: 3.715

7.  Genome-wide screen in Francisella novicida for genes required for pulmonary and systemic infection in mice.

Authors:  Petra S Kraemer; Allison Mitchell; Mark R Pelletier; Larry A Gallagher; Mike Wasnick; Laurence Rohmer; Mitchell J Brittnacher; Colin Manoil; Shawn J Skerett; Nina R Salama
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

8.  Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112.

Authors:  Joshua D Hall; Matthew D Woolard; Bronwyn M Gunn; Robin R Craven; Sharon Taft-Benz; Jeffrey A Frelinger; Thomas H Kawula
Journal:  Infect Immun       Date:  2008-10-13       Impact factor: 3.441

9.  Elastic behavior of model membranes with antimicrobial peptides depends on lipid specificity and d-enantiomers.

Authors:  Akari Kumagai; Fernando G Dupuy; Zoran Arsov; Yasmene Elhady; Diamond Moody; Robert K Ernst; Berthony Deslouches; Ronald C Montelaro; Y Peter Di; Stephanie Tristram-Nagle
Journal:  Soft Matter       Date:  2019-02-20       Impact factor: 3.679

10.  The Francisella tularensis pathogenicity island encodes a secretion system that is required for phagosome escape and virulence.

Authors:  Jeffrey R Barker; Audrey Chong; Tara D Wehrly; Jieh-Juen Yu; Stephen A Rodriguez; Jirong Liu; Jean Celli; Bernard P Arulanandam; Karl E Klose
Journal:  Mol Microbiol       Date:  2009-12       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.